Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial-Reference-Cited by-同舟云学术

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

Published:2016-10 Issue:9 Volume:12 Page:1090-1101
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Onuma Yoshinobu,Sotomi Yohei,Shiomi Hiroki,Ozaki Yukio,Namiki Atsuro,Yasuda Satoshi,Ueno Takafumi,Ando Kenji,Furuya Jungo,Igarashi Keiichi,Kozuma Ken,Tanabe Kengo,Kusano Hajime,Rapoza Richard,Popma Jeffrey,Stone Gregg,Simonton Charles,Serruys Patrick,Kimura Takeshi

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

2. Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial;American Heart Journal;2024-09

3. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

4. Variability in research culture across busy catheterisation labs in the Asia-Pacific region;AsiaIntervention;2024-02

5. Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis;Scientific Reports;2023-01-31